PFE Stock | News | Quote | Stock Forum | Saturday, December 28,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Pfizer, Inc. PFE Company Overview $PFE

Stock Message Board http://investorshangout.com/search?q=PFE&...mp;yt1=Go!

Last Updated: Saturday, December 28, 2013 2:40:54 PM

Pfizer, Inc. PFE Current Price and Quotes
Last Price 30.64
Previous Close 30.55 Open 30.76
Daily Range 30.85 - 30.53 52wk Range 32.50 - 24.63
Volume 11,958,458 Dividend 1.04
Average Vol (3m) 25,545,869 Yield 3.3943
Pfizer, Inc. PFE
Company Information

235 East 42nd Street
New York, NY 10017

Website: http://www.pfizer.com
Phone: (212) 573-2323

Pfizer, Inc. PFE
Not Available

Pfizer, Inc. PFE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 29, 2013 10-Q
CIK 0000078003
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Pfizer, Inc. PFE
PFE Security Details

Share Structure

Market Value1 $197,024,553,688 a/o Dec 27, 2013
Shares Outstanding 6,481,070,845 a/o Nov 04, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.05
Shareholders

Shareholders of Record 231,737 a/o Feb 29, 2008
Corporate Actions

Ex. Date Record Date Pay Date
Dividend () Aug 14, 2002 Aug 16, 2002 Sep 05, 2002
Security Notes

Capital Change=shs increased by 2 for 1 split. Ex-date=07-03-95. Rec date=06-01-95. Pay date=06-30-95
Latest Secondary Issue=11-72, 703,447 shs at $43 by Lazard Freres & Co. et al.
Par Changed=10 cents to 5 cents. Basis: 2 for 1 split. Ex-date=07-03-95. Rec date=06-01-95. Pay date=06-30-95
Capital Change=Capital Change=shs increased by 3 for 1 split. . Ex-date=07/01/1999. Rec date=06/02/1999. Pay date=06/30/1999.
Short Selling Data

Short Interest  (%)
Significant Failures to Deliver  No
Transfer Agent(s)



Pfizer, Inc. PFE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 58,986,000 65,259,000 65,165,000 49,269,000
Cost of Revenue 11,334,000 14,076,000 14,788,000 8,459,000
Gross Profit 47,652,000 51,183,000 50,377,000 40,810,000
Operating Expenses

Research and Development 7,870,000 9,074,000 9,483,000 7,824,000
Sales, General and Admin. 16,616,000 18,832,000 18,973,000 15,037,000
Non-Recurring Items 1,880,000 2,930,000 3,145,000 4,398,000
Other 5,175,000 5,544,000 5,364,000 2,877,000
Operating Income 16,111,000 14,803,000 13,412,000 10,674,000
Income From Continuing Operations

Add'l Income/Expense Items (4,031,000) (2,499,000) (3,941,000) -
Earnings Before Interest and Tax 12,080,000 12,304,000 9,471,000 10,674,000
Interest Expense - - - -
Earnings Before Tax 12,080,000 12,304,000 9,471,000 10,674,000
Income Tax 2,562,000 3,909,000 1,153,000 2,145,000
Minority Interest 28,000 40,000 31,000 8,000
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 9,518,000 8,395,000 8,318,000 8,529,000
Non Recurring Events

Discontinued Operations 5,080,000 1,654,000 (30,000) 114,000
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 14,570,000 10,009,000 8,257,000 8,635,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 14,570,000 10,009,000 8,257,000 8,635,000

Pfizer, Inc. PFE Recent News

Dec 24, 2013 Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD
Dec 20, 2013 Patent Settlements, Stock Price Movements, and Financial Guidance - Research Report on Pfizer, Tenet, Rockwell Medical, Magellan Health Services, and HealthSouth
Dec 19, 2013 FDA Accepts For Review ELIQUIS(R) (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE
Dec 19, 2013 Athersys Confirms Completion of Patient Enrollment of Pfizer's Phase II Study of MultiStem(R) Cell Therapy for Ulcerative Colitis
Dec 18, 2013 Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept
Dec 17, 2013 Teva Settles Viagra(R) Patent Litigation with Pfizer
Dec 17, 2013 Pfizer Settles Viagra(R) Patent Litigation With Teva
Dec 17, 2013 Pfizer Invites Public To View And Listen To Webcast Of January 28 Conference Call With Analysts
Dec 17, 2013 Pfizer Names Albert Bourla Group President; Vaccines, Oncology and Consumer Healthcare Business
Dec 17, 2013 Research and Markets: Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - Pipeline Forecast & Market Forecast in G8 Countries (2011 - 2020)

1
2
3
4
5
6
7
8
next >
last >>

PFE Pfizer, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=PFE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/PFE/quote
Stock Chart http://www.otcmarkets.com/stock/PFE/chart
Company Info http://www.otcmarkets.com/stock/PFE/company-info
Recent News http://www.otcmarkets.com/stock/PFE/news
Financials http://www.otcmarkets.com/stock/PFE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/PFE/filings
Short Sales http://www.otcmarkets.com/stock/PFE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/PFE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/PFE/research
Summary http://finance.yahoo.com/q?s=PFE
Historical Prices http://finance.yahoo.com/q/hp?s=PFE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=PFE
Basic Chart http://finance.yahoo.com/q/bc?s=PFE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PFE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=PFE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=PFE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=PFE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=PFE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=PFE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=PFE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=PFE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=PFE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=PFE
Balance Sheet http://finance.yahoo.com/q/bs?s=PFE
Cash Flow http://finance.yahoo.com/q/cf?s=PFE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/PFE
Market Watch http://www.marketwatch.com/investing/stock/PFE
Bloomberg http://www.bloomberg.com/quote/PFE:US
Morningstar http://quotes.morningstar.com/stock/s?t=PFE
Bussinessweek http://investing.businessweek.com/research/st...ticker=PFE
Barchart http://www.barchart.com/quotes/stocks/PFE
OTC Short Report http://otcshortreport.com/index.php?index=PFE
Investopedia http://www.investopedia.com/markets/stocks/PFE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 61

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
West Virginia Water Gains: Central Grove Upgrade Begins

Updated Category News Views 74

Kickoff at Central Grove: What’s Brewing? Ever wander through Kearneysville, W.Va., and wonder what’s going on with that bustling crew near Goldenrod Drive? The folks at West Virginia American Water have kicked off groundwork for the much-anticipated Central Grove Water Treatment Plant. This, comrades, isn’t just some shiny new shed we’re talking about. Oh no,...

Continue Reading
Delta Dental Expands Free Oral Care Access in NM

Updated Category News Views 107

Bridging Dental Care Gaps in New Mexico When the calendar flips to early November, Delta Dental of New Mexico is joining hands with the NM Mission of Mercy for a no-cost dental clinic at EXPO New Mexico. We're talking doors flying open at 5:15 a.m. sharp, on November 6 and 7. This isn’t some run-of-the-mill thing—they are targeting those who can't easily get or afford...

Continue Reading
Soligenix Holds Steady Amidst Shifting Financial Landscape

Updated Category News Views 47

Stepping into Soligenix's News Every time Soligenix pops up on the radar, it feels like we're watching a biopharma soap opera. This time, they're juggling updates and quarterly numbers that scream both promise and peril. The New Jersey-based company, known for its focus on niche markets with unmet medical needs, tossed out some shiny clinical developments alongside a...

Continue Reading
Yiren Digital's Tumble: Lawsuit Timeline for Investors

Updated Category News Views 59

Yiren's Stock Plunge and the Legal Quagmire What a mess Yiren Digital Ltd. (NYSE:YRD) finds itself in, huh? We're looking at a stunning 44.05% stock nosedive that's left a trail of bruised investors in its wake. Now that's a real gut-punch for any portfolio hugging YRD. So, what's spinning this cycle of chaos for our digital player from across the pond? The Flash Point:...

Continue Reading
CalExitNow Push for CA GOP Ban & Sovereignty Talks

Updated Category News Views 116

California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...

Continue Reading
Lilly's Digital Healthcare Push with Hims & Hers

Updated Category News Views 124

Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...

Continue Reading
Recovery 180's Landmark Facility: Community Impact Unfolds

Updated Category News Views 68

Taneytown Takes a Significant Leap Well, Taneytown's making noise, folks. Never thought this sleepy spot would pull off something so important, but here we are with Recovery 180 opening Taneytown’s first-ever residential Level 3.1 treatment facility. After four years of struggle, the largest venture in Carroll County is opening its doors to residents who desperately...

Continue Reading
Kestrel Group Faces Financial Hit Despite Revenue Growth

Updated Category News Views 97

Kestrel's Financial Rollercoaster Continues Here's the deal with Kestrel Group, folks. They just dropped their Q3 2026 financials, and it's a mixed bag. The top line's looking solid with total revenues hitting $4.8 million, riding high on a 203% jump in Program Services fee income. But dig a little deeper, and there's a $16.4 million net loss staring us in the face....

Continue Reading
ALMIA's Bold Medicare Defense to HHS Committee

Updated Category News Views 67

ALMIA Lays It Out for Medicare Stakeholders The folks at ALMIA are shaking things up, and they're not pulling any punches with the HHS Healthcare Advisory Committee. With this latest move, they've lobbed public comments towards the committee, especially ahead of this intense November 9th meeting. It's part of a larger dialogue kicked off with the Strengthening Medicare...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: Legal Action Against Sable Offshore Corp. Securities

Updated Category News Views 137

Legal Issues Surrounding Sable Offshore Corp. There’s a growing concern among investors regarding Sable Offshore Corp. (NYSE: SOC). The DJS Law Group has taken the initiative to investigate potential violations of securities laws that could impact shareholders significantly. Investors must stay informed to protect their investments amid allegations of misrepresentation...

Continue Reading
FTI Consulting Achieves Robust Earnings Despite Market Challenges

Updated Category News Views 64

FTI Consulting Reports Third Quarter Financial Results FTI Consulting, Inc. (NYSE: FCN) recently announced its financial performance for the third quarter, presenting a noteworthy achievement with earnings of $926 million, marking an increase compared to the previous year. This growth reflects the company's resilience and capacity to adapt amidst fluctuating market...

Continue Reading
Columbus McKinnon Sees Strong Order Growth in Q2 FY25

Updated Category News Views 188

Columbus McKinnon Records Significant Order Growth Columbus McKinnon Corporation (NASDAQ: CMCO) has successfully announced financial performance results reflecting notable progress within the second quarter of its fiscal year 2025. The company, recognized as a leading designer and manufacturer of intelligent motion solutions, achieved a 16% increase in order volume...

Continue Reading
Rhode Island Commerce Celebrates 250 Years of History

Updated Category News Views 309

Rhode Island Commerce Partners with The HISTORY Channel In an exciting initiative commemorating America’s 250th anniversary, Rhode Island Commerce, which serves as the state’s primary economic development agency, has formed a partnership with The HISTORY Channel. This collaboration aims to celebrate Rhode Island's rich heritage as part of the larger project known as...

Continue Reading
Istanbul Market Sees Minor Decline Amidst Select Gains

Updated Category News Views 130

Overview of Istanbul Stock Exchange Performance The recent performance of Turkey's stock market has shown a bit of volatility, particularly noted after the last trading session. As the market closed, several sectors experienced losses, especially in Banking, Sports, and Financials. Despite these challenges, some stocks managed to edge upwards, providing a glimmer of hope...

Continue Reading